NR 565 - advanced pharmacology Practice Exam - Chamberlain College
NR 565 - ADVANCED PHARMACOLOGY PRACTICE EXAM -
CHAMBERLAIN COLLEGE NEWEST 2026/2027 ACTUAL EXAM
COMPLETE 100 QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+|BRAND NEW
VERSION!!
An 18 year old asthmatic patient reports to their routine annual exam. The patient
reports asthma symptoms occur 4-5 times a week with once weekly night time
exacerbations. The patient is most likely diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
B. Mild-peristant asthma
A 33 year old asthmatic patient reports asthma symptoms that occur daily with
night time exacerbations occurring 4-5 times a week. The patient is mostly like
diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
C. Moderate-persistant asthma
1|Page
, NR 565 - advanced pharmacology Practice Exam - Chamberlain College
In management of asthma, step 1 therapy includes
A. Increase fluid intake and oxygen as needed
B. Short-Acting Beta Agonists (SABA) as needed
C. Inhaled corticosteroids (ICS)
D. Omalizumab
B. Short-Acting Beta Agonists (SABA) as needed
A 26 year old asthmatic patient reports asthma symptoms that occur several times
a day with nightly exacerbations. The patient is mostly like diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
D. Severe asthma
What is the the therapeutic goal of inhaled corticosteroids (ICS)?
A. To achieve symptom control through suppression of airway inflammation.
B. To produce bronchodilation by relaxing smooth muscle of the bronchi
C. To decrease the intensity and frequency of moderate to severe asthma attacks
and to control chronic obstructive pulmonary disease exacerbations through
bronchodilation.
D. To reduce inflammation by suppressing cytokine release and by decreasing
pulmonary infiltration by neutrophils and other white blood cells.
A. To achieve symptom control through suppression of airway inflammation.
2|Page
, NR 565 - advanced pharmacology Practice Exam - Chamberlain College
Which patient population is at most risk for methylxanthine toxicity?
A. Asians
B. Women of child-bearing age
C. Diabetics
D. Older adults
D. Older adults
Which of the following medications is a long-acting beta agonists (LABA)?
A. Methylprednisolone
B. Budesonide
C. Salmeterol
D. Zafirlukast
C. Salmeterol
The correct drug classification of Ciclesonide is
A. Methylazanthine
B. Inhaled Corticosteroid
C. Short-acting Beta Agonist
D. Leukotriene Receptor Antagonist
B. Inhaled Corticosteroid
A 29 year old patient reports asthma symptoms occurring twice a week with one
night time exacerbation last month. Which medication would the NP most likely
prescribe?
A. Levalbuterol
3|Page
NR 565 - ADVANCED PHARMACOLOGY PRACTICE EXAM -
CHAMBERLAIN COLLEGE NEWEST 2026/2027 ACTUAL EXAM
COMPLETE 100 QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED A+|BRAND NEW
VERSION!!
An 18 year old asthmatic patient reports to their routine annual exam. The patient
reports asthma symptoms occur 4-5 times a week with once weekly night time
exacerbations. The patient is most likely diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
B. Mild-peristant asthma
A 33 year old asthmatic patient reports asthma symptoms that occur daily with
night time exacerbations occurring 4-5 times a week. The patient is mostly like
diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
C. Moderate-persistant asthma
1|Page
, NR 565 - advanced pharmacology Practice Exam - Chamberlain College
In management of asthma, step 1 therapy includes
A. Increase fluid intake and oxygen as needed
B. Short-Acting Beta Agonists (SABA) as needed
C. Inhaled corticosteroids (ICS)
D. Omalizumab
B. Short-Acting Beta Agonists (SABA) as needed
A 26 year old asthmatic patient reports asthma symptoms that occur several times
a day with nightly exacerbations. The patient is mostly like diagnosed with:
A. Intermittent asthma
B. Mild-peristant asthma
C. Moderate-persistant asthma
D. Severe asthma
D. Severe asthma
What is the the therapeutic goal of inhaled corticosteroids (ICS)?
A. To achieve symptom control through suppression of airway inflammation.
B. To produce bronchodilation by relaxing smooth muscle of the bronchi
C. To decrease the intensity and frequency of moderate to severe asthma attacks
and to control chronic obstructive pulmonary disease exacerbations through
bronchodilation.
D. To reduce inflammation by suppressing cytokine release and by decreasing
pulmonary infiltration by neutrophils and other white blood cells.
A. To achieve symptom control through suppression of airway inflammation.
2|Page
, NR 565 - advanced pharmacology Practice Exam - Chamberlain College
Which patient population is at most risk for methylxanthine toxicity?
A. Asians
B. Women of child-bearing age
C. Diabetics
D. Older adults
D. Older adults
Which of the following medications is a long-acting beta agonists (LABA)?
A. Methylprednisolone
B. Budesonide
C. Salmeterol
D. Zafirlukast
C. Salmeterol
The correct drug classification of Ciclesonide is
A. Methylazanthine
B. Inhaled Corticosteroid
C. Short-acting Beta Agonist
D. Leukotriene Receptor Antagonist
B. Inhaled Corticosteroid
A 29 year old patient reports asthma symptoms occurring twice a week with one
night time exacerbation last month. Which medication would the NP most likely
prescribe?
A. Levalbuterol
3|Page
